Masimo | MASI - Current Assets


Masimo reported $1.05B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 24.84B 371M Sep/2025
Align Technology USD 2.53B 86.04M Sep/2025
AtriCure USD 301.11M 29.85M Sep/2025
Avanos Medical USD 351.4M 4.6M Sep/2025
Baxter International USD 6.93B 184M Sep/2025
Becton, Dickinson and Co. USD 9.26B 258M Sep/2025
Boston Scientific USD 8.04B 914M Sep/2025
Dexcom USD 5.22B 189.3M Sep/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
General Electric Aerospace USD 40.6B 522M Dec/2025
Globus Medical USD 1.92B 194.46M Sep/2025
Haemonetics USD 899.68M 13.48M Sep/2025
Insulet USD 1.86B 420.3M Sep/2025
Integra LifeSciences USD 1.14B 754K Sep/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
Masimo USD 1.05B 221.5M Sep/2025
Medtronic USD 23.22B 591M Jun/2025
Owens Minor USD 2.13B 166.84M Sep/2025
ResMed USD 3.82B 193.06M Dec/2025
Steris USD 2.11B 48.5M Sep/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 616.94M 2.13M Sep/2025
Teleflex USD 1.99B 262.12M Sep/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Zimmer Biomet Holdings USD 5.83B 781M Sep/2025